Curium Announces Rev
Curium Announces Revised Pricing for Technescan MAG3TM
September 04, 2019 08:30 ET | Curium
St. Louis, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it is implementing a new pricing model for Technescan MAG3.  Curium is phasing out its pay per dose sales model, in which...
20170406 Telix Logo.png
Telix Pharmaceuticals and Grupo RPH Sign LATAM Manufacturing and Distribution Agreement
July 02, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and PORTO ALEGRE, Brazil, July 03, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
20170406 Telix Logo.png
Telix Pharmaceuticals e Grupo RPH firmam Contrato de Manufatura e Distribuição para a LATAM
July 02, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Austrália e PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- A Telix Pharmaceuticals Limited (ASX.TLX) ( “Telix”, a “Empresa”), uma empresa biofarmacêutica de fase clínica...
20170406 Telix Logo.png
Telix Pharmaceuticals y Grupo RPH firman acuerdo de fabricación y distribución en América Latina 
July 02, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia y PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, la “Compañía”), una compañía biofarmacéutica en fase-clínica,...
logo.jpg
RENNOVA HEALTH’S BIG SOUTH FORK MEDICAL CENTER, TN, COMPLETES INSTALLATION OF GE 64 SLICE CT SCANNER
August 27, 2018 09:20 ET | Rennova Health, Inc.
WEST PALM BEACH, Fla, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the “Company”) a vertically integrated provider of industry-leading diagnostics...
20170406 Telix Logo.png
Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research
May 29, 2018 19:00 ET | Telix Pharmaceuticals Limited
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
UCLE
Us Nuclear Corp to Become Miftec’s Exclusive Manufacturer of New Medical Isotope Generators
December 07, 2017 13:25 ET | US Nuclear Corp.
LOS ANGELES, CA, Dec. 07, 2017 (GLOBE NEWSWIRE) -- US Nuclear Corp (OTCBB: UCLE) has signed a letter of intent with MIFTEC to become the exclusive contractor to manufacture medical isotope...
Logo-BCC-Research.jpg
Radiopharmaceutical Regional Markets to See Double-Digit Growths, Reports BCC Research
January 26, 2017 05:00 ET | BCC Research
Wellesley, Mass, Jan. 26, 2017 (GLOBE NEWSWIRE) -- A growing and aging population, increasing life expectancy, and improved diagnostic modalities are key factors in market growth for...